Dylan Hartley is Chief Scientific Officer. Dr. Hartley has over 20 years of experience in drug research and development, including expertise in pharmacology, toxicology, drug metabolism and pharmacokinetics. Previously, Dr. Hartley served as Vice President, Head of Research at Pfizer Inc.’s Boulder facility (previously Array BioPharma), where he led drug discovery research and oversaw small molecule discovery from target identification though IND submission and into clinical development. He holds a B.A. in biological sciences from the University of Northern Colorado and a Ph.D. in pharmaceutical sciences from the University of Colorado Health Sciences Center.
